Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Amid market volatility, Nvidia-backed Firmus withdraws major IPO

Amid market volatility, Nvidia-backed Firmus withdraws major IPO

智通财经智通财经2026/10/09 06:36
Show original

(1) Firmus, an Australian AI data center operator backed by Nvidia, has withdrawn its planned major initial public offering (IPO) due to market volatility and conditions, according to a statement the company sent to CNBC. (2) Firmus stated that its board determined the proposed offering terms did not adequately reflect its business strength and long-term growth prospects. (3) The statement said, "Therefore, the board has concluded that proceeding with this offering is not in the best interests of the company and its shareholders." Firmus added that it will now seek capital from the private market and consider other public and private market options. (4) Reportedly, Firmus had planned to raise 5 billions USD in the IPO, pricing shares at 11 AUD each, which would have made it the second-largest new share issue in Australian history. The IPO valued the company at approximately 30.6 billions USD. (5) In August, the company announced a 2 billions USD financing round, backed by Nvidia, Coatue Management, Blackstone, and Jane Street, bringing its total equity raised in the past year to over 3 billions USD, with a valuation exceeding 10.5 billions USD. (6) Last month, Firmus also announced an agreement with Meta to provide GPU computing power in its Southeast Asian AI data centers. These centers are built on Nvidia's DSX platform to support Meta's AI research, model development, and training.

(1) The Australian AI data center operator Firmus, backed by Nvidia, has withdrawn its planned large initial public offering (IPO), citing market volatility and conditions. The company stated this in an email statement sent to CNBC. (2) Firmus said that the board determined the proposed offer terms did not sufficiently reflect its business strength and long-term growth prospects. (3) The statement said: “As a result, the board concluded that it is not in the best interests of the company and its shareholders to proceed with the offering.” Firmus added that it will now seek capital from the private market and consider other public and private market options. (4) It was reported that Firmus had planned to raise $5 billion in the IPO, with a price set at 11 Australian dollars per share, which would have made it the second-largest new share issue in Australian history. The IPO valued the company at about $30.6 billion. (5) In August, the company announced a $2 billion funding round backed by Nvidia, Coatue Management, Blackstone, and Jane Street, bringing the total equity raised in the past year to over $3 billion and the valuation to over $10.5 billion. (6) Last month, Firmus also announced an agreement with Meta to provide GPU computing capacity at its AI data centers in Southeast Asia. These data centers are built on Nvidia’s DSX platform to support Meta’s AI research, model development, and training.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Coreweave discusses data center cooperation with South Korea

According to ZDNet, Coreweave (CRWV.US) is in discussions with South Korea regarding cooperation on data centers.

智通财经•2026/10/09 07:31

Sberbank of Russia reported a net profit of 168.5 billions rubles in September

Sberbank of Russia announced that, according to Russian accounting standards, its net profit for September was 168.5 billion rubles.

智通财经•2026/10/09 07:15

The yield on France's 10-year government bond dropped by 8 basis points to 4.82%.

France leads the eurozone bond market, with the 10-year government bond yield falling by 8 basis points to 4.82%.

智通财经•2026/10/09 07:15

Even with Eli Lilly's endorsement, TRex Bio (TRXB.US) struggles to enjoy a premium; IPO price falls to lower range at $14.

According to Zhitong Finance APP, TRex Bio Inc., an early-stage biotechnology company focused on autoimmune and inflammatory diseases, raised 116.7 million dollars through its IPO, pricing at the lower end of its indicated range.

智通财经•2026/10/09 07:07